Market Access Six takeaways from JP Morgan 2024 With another JP Morgan in the rearview mirror, it’s time to take stock of the announcements, the presentations, and, above all, the vibes.
R&D Nine for 2024, Pt 2: Phase change and the challenges of scal... In the first segment of Nine for 2024, we examined the continued fragility of healthcare systems, global pharmaceutical market infrastructure, and the journey to greater resilience.
Sales & Marketing Sponsored Top 5 pharma marketing trends in 2024 2023 was a year of many innovations and changes.
Sales & Marketing Life sciences marketing ahead: Unveiling the role of AI-powe... The life sciences, just like any other industry, has been undergoing a paradigm shift, owing to rising digital adoption in the past few years.
Sales & Marketing Sponsored 12 Questions with Marcus West Marcus West grew up in a family of educators. His mother is a historian and his father a headmaster.
Sales & Marketing Navigating the path to sustainable pharma: Insights from sus... In the dynamic landscape of life sciences, the importance of Environmental, Social, and Governance (ESG) considerations has never been more evident.
News FDA issues warning letters to five unapproved GLP-1 websites In a handful of strongly-worded warning letters, the FDA is cracking down on sales of unapproved peptides - even if they're labelled for research.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
